Dr Reddys Laboratories (RDY) Tax Rate (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Tax Rate of 21.32% for Q2 2026, up 101.96% on a QoQ basis from 1088.16% in Q1 2026, and down 468.0% year-over-year from 5.79% in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) Tax Rate (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Tax Rate for 18 years, with the latest figure at 21.32% in Q2 2026.
- On a quarterly basis, Tax Rate fell 468.0% year-over-year to 21.32% in Q2 2026; TTM through Jun 2026 was 408.86%, a 38339.0% increase from a year earlier, with the FY2026 full-year figure at 22.6%, down 246264.0% from the prior year.
- Tax Rate was 21.32% for Q2 2026 at Dr Reddys Laboratories, up from 1088.16% in the prior quarter.
- The five-year high for Tax Rate was 1197.05% in Q4 2025, with the low at 1088.16% in Q1 2026.
- Average Tax Rate over 5 years is 29.5%, with a median of 24.17% recorded in 2023.
- The sharpest annual moves came in 2025 and 2026: Tax Rate jumped 117195 bps in 2025, then plunged 110901 bps in 2026.
- Over 5 years, Tax Rate stood at 27.78% in 2022, then decreased by 12 bps to 24.47% in 2023, then grew by 3 bps to 25.1% in 2024, then jumped by 4669 bps to 1197.05% in 2025, then plunged by 98 bps to 21.32% in 2026.
- The last three Tax Rate figures came in at 21.32% (Q2 2026), 1088.16% (Q1 2026), and 1197.05% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.74 Bn | 39.09 Bn | 2.15 Bn | -26.59% |
| 2 | Viatris | 19.12 Bn | 18.23 Bn | 1.46 Bn | -85.63% |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 21.32% |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn | 1.94% |
| 5 | Bausch Health Companies | 2.37 Bn | 530.13 Mn | 2.10 Bn | 25.29% |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | 0.09% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 33.43% |
| 8 | Amphastar Pharmaceuticals | 991.81 Mn | 701.69 Mn | 93.47 Mn | 21.26% |
| 9 | Fennec Pharmaceuticals | 412.12 Mn | 370.87 Mn | 17.15 Mn | 2.08% |
| 10 | RedHill Biopharma | 182.76 Mn | 182.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.32% |
| Mar 31, 2026 | -1,088.16% |
| Dec 31, 2025 | 1,197.05% |
| Sep 30, 2025 | 22.25% |
| Jun 30, 2025 | 25.99% |
| Mar 31, 2025 | 20.85% |
| Dec 31, 2024 | 25.10% |
| Sep 30, 2024 | 30.01% |
| Jun 30, 2024 | 26.04% |
| Mar 31, 2024 | 18.39% |
| Dec 31, 2023 | 24.47% |
| Sep 30, 2023 | 22.65% |
| Jun 30, 2023 | 26.09% |
| Mar 31, 2023 | 23.87% |
| Dec 31, 2022 | 27.78% |
| Sep 30, 2022 | 23.62% |
| Jun 30, 2022 | 18.96% |
| Mar 31, 2022 | 64.76% |
| Dec 31, 2021 | 40.74% |
| Sep 30, 2021 | 27.34% |